These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 20175830)

  • 1. Case of livedoid vasculopathy with peripheral neuropathy successfully treated with low-dose warfarin.
    Osada S; Kimura Y; Kawana S
    J Dermatol; 2010 Jan; 37(1):98-101. PubMed ID: 20175830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Livedoid vasculopathy; favorable clinical response with low dose warfarin.
    Nakamura S; Kishibe M; Nishi K; Hashimoto Y; Takeda K; Mizumoto T; Iizuka H
    Eur J Dermatol; 2011; 21(6):1011-2. PubMed ID: 21914587
    [No Abstract]   [Full Text] [Related]  

  • 3. [Vasculitis and vasculopathy].
    Marković A
    Acta Med Croatica; 2012 Oct; 66 Suppl 1():19-24. PubMed ID: 23193816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of livedoid vasculopathy associated with factor V Leiden mutation: successful treatment with oral warfarin.
    Kavala M; Kocaturk E; Zindanci I; Turkoglu Z; Altintas S
    J Dermatolog Treat; 2008; 19(2):121-3. PubMed ID: 18484430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ulcerations caused by livedoid vasculopathy associated with a prothrombotic state: Response to warfarin.
    Davis MD; Wysokinski WE
    J Am Acad Dermatol; 2008 Mar; 58(3):512-5. PubMed ID: 18280355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Livedoid vasculopathy: review of pathogenesis, clinical presentation, diagnostic workup, and treatment.
    Haunson GT; Judy DW; Prall NC; Miller RA
    Cutis; 2012 Dec; 90(6):302-6. PubMed ID: 23409480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Livedoid vasculopathy. Pathogenesis, diagnosis and treatment of cutaneous infarction].
    Goerge T
    Hautarzt; 2011 Aug; 62(8):627-34; quiz 635. PubMed ID: 21786003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Livedoid vasculopathy associated with plasminogen activator inhibitor-1 promoter homozygosity (4G/4G) treated successfully with tissue plasminogen activator.
    Deng A; Gocke CD; Hess J; Heyman M; Paltiel M; Gaspari A
    Arch Dermatol; 2006 Nov; 142(11):1466-9. PubMed ID: 17116837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Livedoid vasculopathy with underlying subcutaneous necrotizing venulitis in an asymptomatic hepatitis B virus carrier: is livedoid vasculopathy a true nonvasculitic disorder?
    Ishibashi M; Miyamoto J; Nagasaka T; Chen KR
    Am J Dermatopathol; 2009 May; 31(3):293-6. PubMed ID: 19384073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Warfarin therapy for livedoid vasculopathy associated with cryofibrinogenemia and hyperhomocysteinemia.
    Browning CE; Callen JP
    Arch Dermatol; 2006 Jan; 142(1):75-8. PubMed ID: 16415390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Livedoid vasculopathy and hypercoagulability in a patient with primary Sjögren's syndrome.
    Cardoso R; Gonçalo M; Tellechea O; Maia R; Borges C; Silva JA; Figueiredo A
    Int J Dermatol; 2007 Apr; 46(4):431-4. PubMed ID: 17442092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Livedoid vasculopathy - current aspects of diagnosis and treatment of cutaneous infarction.
    Kerk N; Goerge T
    J Dtsch Dermatol Ges; 2013 May; 11(5):407-10. PubMed ID: 23437985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Livedoid vasculopathy - a thrombotic disease.
    Kerk N; Goerge T
    Vasa; 2013 Sep; 42(5):317-22. PubMed ID: 23989066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterozygous prothrombin gene mutation associated with livedoid vasculopathy.
    Anavekar NS; Kelly R
    Australas J Dermatol; 2007 May; 48(2):120-3. PubMed ID: 17535202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of new low-dose oral anticoagulants in recalcitrant livedoid vasculopathy.
    Furukawa F; Mizawa M; Makino T; Shimizu T
    BMJ Case Rep; 2017 Jul; 2017():. PubMed ID: 28739563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Case of livedoid vasculopathy with extensive dermal capillary thrombi.
    Shimizu A; Tamura A; Yamanaka M; Amano H; Nagai Y; Ishikawa O
    J Dermatol; 2010 Jan; 37(1):94-7. PubMed ID: 20175829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Negative Results, Positive Outcome: A Case of Primary Livedoid Vasculopathy With an Elusive Laboratory Workup.
    Al-Obaidi AD; Sabeeh SK; Mohammed MJ; Othman A; Algburi YA; Hashim HT; Alhatemi AQM; Al Hilali Z; Al-Attabi BRT; Al-Awad A
    J Investig Med High Impact Case Rep; 2024; 12():23247096241266090. PubMed ID: 39068597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Livedoid vasculopathy secondary to high levels of lipoprotein(a).
    Vasconcelos R; Criado PR; Belda W
    Br J Dermatol; 2011 May; 164(5):1111-3. PubMed ID: 21219292
    [No Abstract]   [Full Text] [Related]  

  • 19. Livedoid vasculopathy: an intringuing cutaneous disease.
    Criado PR; Rivitti EA; Sotto MN; Valente NY; Aoki V; Carvalho JF; Vasconcellos C
    An Bras Dermatol; 2011; 86(5):961-77. PubMed ID: 22147037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of intravenous immunoglobulins in livedoid vasculopathy: long-term follow-up of 11 patients.
    Monshi B; Posch C; Vujic I; Sesti A; Sobotka S; Rappersberger K
    J Am Acad Dermatol; 2014 Oct; 71(4):738-44. PubMed ID: 25022849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.